(Q43855810)

27 November 2017

title

Impact of generic substitution practice on care of diabetic patients (English)

1 reference

27 November 2017

Olubukola O Oyetunde

1

1 reference

27 November 2017

Bolajoko A Aina

series ordinal

2

1 reference

27 November 2017

Fola Tayo

series ordinal

3

1 reference

27 November 2017

publication date

10 April 2014

1 reference

International Journal of Clinical Pharmacy

27 November 2017

published in

1 reference

27 November 2017

volume

36

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

623-629

1 reference

https://scigraph.springernature.com/pub.10.1007/s11096-014-9946-5

27 November 2017

exact match

0 references

cites work

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

What's in a name? Use of brand versus generic drug names in United States outpatient practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

Physicians' attitudes about prescribing and knowledge of the costs of common medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

Generic drug policy in Australia: a community pharmacy perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

Prescription of generic drugs in general practice. Results of a survey of general practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

Physicians underestimate the frequency of generic carbamazepine substitution: results of a survey and review of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

A comparative analysis of generics markets in five European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-014-9946-5

American Academy of Pediatrics Committee on Drugs: Generic prescribing, generic substitution, and therapeutic substitution

21 January 2018

1 reference

12 December 2020

Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008): Results of a multicenter study

1 reference

12 December 2020

What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden

1 reference

12 December 2020

1 reference

12 December 2020

Consumer perceptions of risk and required cost savings for generic prescription drugs

1 reference

12 December 2020

Association of income and prescription drug coverage with generic medication use among older adults with hypertension

1 reference

12 December 2020

Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans

1 reference

12 December 2020

The elephant in the pharmacy: patient choice is the big challenge that no one talks about in affordability of prescription drugs.

1 reference

12 December 2020

Consumers' views on generic medicines: a review of the literature

1 reference

12 December 2020

Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland

1 reference

12 December 2020

10.1007/S11096-014-9946-5

Identifiers

DOI

1 reference

27 November 2017

1 reference